+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Delpor Inc - logo

Delpor company enables the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant device. They use 3 different technologies: Prozor, Nanopor, and Delos Pump. Delpor was founded in 2009, its headquarters is situated in San Francisco, California. Delpors DLP-114 is a 3-6 month formulation of Risperidone. This product is using Delpors Prozor technology It is expected to maintain therapeutic levels of Risperidone and its active metabolite in human plasma.

Bipolar Disorder (Manic Depression) - Pipeline Insight, 2020 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
Spasticity - Pipeline Insight, 2022 - Product Thumbnail Image

Spasticity - Pipeline Insight, 2022

  • Clinical Trials
  • November 2022
  • 106 Pages
From
Dopaminergic system Antagonist - Pipeline Insight, 2022 - Product Thumbnail Image

Dopaminergic system Antagonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 120 Pages
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
From
D1 Antagonist - Pipeline Insight, 2022 - Product Thumbnail Image

D1 Antagonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
Loading Indicator